Literature DB >> 19956779

Microcystoid maculopathy associated with tamoxifen use diagnosed by high-resolution fourier-domain optical coherence tomography.

Susanna S Park1, Robert J Zawadzki, Steven N Truong, Stacey S Choi, John S Werner.   

Abstract

PURPOSE: To describe a case of microcystoid maculopathy diagnosed by high-resolution Fourier-domain optical coherence tomography (Fd-OCT) in a patient treated with tamoxifen who had previously unexplained vision loss.
METHODS: Report of a case of a 66-year-old woman treated with tamoxifen for 4 years who had progressive unexplained vision loss in the left eye for 2 years.
RESULTS: Visual acuity was 20/25 in the right eye and 20/70 in the left eye. Findings of funduscopy and fluorescein angiography were unremarkable except for minimal pigment alteration in the macula in the left eye. Stratus OCT showed possible microcystoid changes in the fovea in both eyes. Fd-OCT revealed scattered intraretinal microcystoid changes and patches of focal loss of photoreceptors in the macula in both eyes with foveal involvement in the left eye. Full-field electroretinogram was normal. Multifocal electroretinogram showed some decreased response in the peripheral macula and borderline low foveal response in both eyes.
CONCLUSION: Microcystoid maculopathy associated with tamoxifen use can be diagnosed by Fd-OCT in a normal appearing fundus. It can present as unexplained vision loss.

Entities:  

Year:  2009        PMID: 19956779      PMCID: PMC2739379          DOI: 10.1097/ICB.0b013e31815e93cf

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  5 in total

1.  Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography.

Authors:  Lelia A Paunescu; Tony H Ko; Jay S Duker; Annie Chan; Wolfgang Drexler; Joel S Schuman; James G Fujimoto
Journal:  Ophthalmology       Date:  2005-12-15       Impact factor: 12.079

2.  Tamoxifen retinopathy at low dosage.

Authors:  M F Griffiths
Journal:  Am J Ophthalmol       Date:  1987-08-15       Impact factor: 5.258

3.  Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging.

Authors:  Suhail Alam; Robert J Zawadzki; Stacey Choi; Christina Gerth; Susanna S Park; Lawrence Morse; John S Werner
Journal:  Ophthalmology       Date:  2006-06-12       Impact factor: 12.079

4.  Optical coherence tomography findings in tamoxifen retinopathy.

Authors:  Vincent Gualino; Salomon Y Cohen; Marie-Noëlle Delyfer; José-Alain Sahel; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2005-10       Impact factor: 5.258

5.  Tamoxifen retinopathy. A clinicopathologic report.

Authors:  M I Kaiser-Kupfer; C Kupfer; M M Rodrigues
Journal:  Ophthalmology       Date:  1981-01       Impact factor: 12.079

  5 in total
  3 in total

1.  Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.

Authors:  Eric K Chin; Dae Yu Kim; Allan A Hunter; Suman Pilli; Machelle Wilson; Robert J Zawadzki; John S Werner; Susanna S Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-02       Impact factor: 4.799

2.  Maculopathy diagnosed with high-resolution fourier-domain optical coherence tomography in eyes with previously unexplained visual loss.

Authors:  Susanna S Park; Robert J Zawadzki; Stacey S Choi; John S Werner
Journal:  Retin Cases Brief Rep       Date:  2010

Review 3.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.